LSERS
CTKB icon

Louisiana State Employees Retirement System’s Cytek Biosciences CTKB Stock Holding History

Louisiana State Employees Retirement System’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
48,800
-1,600
-3% -$7.55K ﹤0.01% 1508
2025
Q4 		$255K Buy
50,400
+100
+0.2% +$464 ﹤0.01% 1491
2025
Q3 		$175K Buy
50,300
+2,400
+5% +$9.01K ﹤0.01% 1514
2025
Q2 		$163K Sell
47,900
-1,200
-2% -$4K ﹤0.01% 1515
2025
Q1 		$197K Sell
49,100
-1,300
-3% -$6.74K ﹤0.01% 1512
2024
Q4 		$327K Sell
50,400
-1,100
-2% -$6.55K 0.01% 1459
2024
Q3 		$285K Buy
51,500
+3,300
+7% +$18.7K 0.01% 1488
2024
Q2 		$269K Sell
48,200
-800
-2% -$4.8K 0.01% 1482
2024
Q1 		$329K Sell
49,000
-500
-1% -$3.96K 0.01% 1457
2023
Q4 		$451K Sell
49,500
-1,200
-2% -$7.55K 0.01% 1369
2023
Q3 		$280K Buy
50,700
+8,700
+21% +$69.8K 0.01% 1459
2023
Q2 		$359K Buy
+42,000
New +$377K 0.01% 1408

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Louisiana State Employees Retirement System's CTKB Position: Q1 2026 in Review

Louisiana State Employees Retirement System reduced its Cytek Biosciences (CTKB) stake by 3.2% in Q1 2026, selling an estimated $7.55K and leaving 48,800 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Louisiana State Employees Retirement System first reported a position in CTKB in Q2 2023 and has held it in 12 quarters since. The position peaked at $451K in Q4 2023. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Louisiana State Employees Retirement System held 48,800 shares of Cytek Biosciences worth $213K as of Q1 2026.
  • Louisiana State Employees Retirement System sold 1,600 Cytek Biosciences shares in Q1 2026, an estimated $7.55K.
  • Cytek Biosciences made up ﹤0.01% of Louisiana State Employees Retirement System's portfolio in Q1 2026, its #1508 holding.
  • Louisiana State Employees Retirement System first reported a position in Cytek Biosciences in Q2 2023 and has held it in 12 quarters since.
  • Louisiana State Employees Retirement System's Cytek Biosciences position peaked at $451K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.